Murugan Amar has filed 14 insider transactions across 1 company since March 2023.
Most recent transaction: a sale of 877 shares of Atara Biotherapeutics, Inc. ($ATRA) on August 16, 2024.
Activity breakdown: 0 open-market purchases and 11 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 16, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | EVP, Chief Legal Officer | S | Common Stock | 877 | $6.63 | 27,108.0000 | 4,236,000 | 3.13% | 0.02% |
| Aug. 16, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | EVP, Chief Legal Officer | S | Common Stock | 192 | $6.63 | 26,916.0000 | 4,236,000 | 0.71% | 0.00% |
| Aug. 16, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | EVP, Chief Legal Officer | S | Common Stock | 89 | $6.63 | 26,827.0000 | 4,236,000 | 0.33% | 0.00% |
| May 16, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | EVP, Chief Legal Officer | S | Common Stock | 32401 | $0.62 | 695,120.0000 | 4,236,000 | 4.45% | 0.76% |
| March 4, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | EVP, Chief Legal Officer | S | Common Stock | 10044 | $0.72 | 727,521.0000 | 4,236,000 | 1.36% | 0.24% |
| Jan. 8, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | EVP, Chief Legal Officer | A | Common Stock | 475000 | $0.00 | 737,565.0000 | 4,236,000 | 180.91% | 11.21% |
| Nov. 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | EVP, Chief Legal Officer | S | Common Stock | 8307 | $0.39 | 257,084.0000 | 0 | 3.13% | 0.00% |
| Aug. 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | EVP, Chief Legal Officer | S | Common Stock | 5050 | $1.65 | 269,013.0000 | 0 | 1.84% | 0.00% |
| Aug. 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | EVP, Chief Legal Officer | S | Common Stock | 3622 | $1.65 | 265,391.0000 | 0 | 1.35% | 0.00% |
| May 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | EVP, Chief Legal Officer | S | Common Stock | 7404 | $2.04 | 271,930.0000 | 0 | 2.65% | 0.00% |
| May 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | EVP, Chief Legal Officer | S | Common Stock | 985 | $2.04 | 270,945.0000 | 0 | 0.36% | 0.00% |
| March 2, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | SVP, GC & Secretary | S | Common Stock | 4221 | $3.63 | 279,334.0000 | 0 | 1.49% | 0.00% |
| March 1, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | SVP, GC & Secretary | A | Common Stock | 155375 | $0.00 | 283,555.0000 | 0 | 121.22% | 0.00% |
| March 1, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Murugan Amar | SVP, GC & Secretary | A | Employee Stock Option (Right to Buy) | 349593 | $0.00 | 349,593.0000 | 0 | 9999.99% | 0.00% |